Discovery could lead to drug therapy for hypopigmentation conditions

An NSAID-related compound called ampyrone appears to safely boost accumulation of the pigment melanin successful quality skin, according to a preclinical survey led by Weill Cornell Medicine and National Eye Institute investigators. The find could pb to the improvement of an ampyrone-derived attraction for hypopigmentation disorders.